RPX Corp. CEO Sells $287,640 in Stock (RPXC)
RPX Corp. (NASDAQ:RPXC) CEO John A. Amster sold 18,800 shares of RPX Corp. stock on the open market in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $15.30, for a total value of $287,640.00. The sale was disclosed in a filing with the SEC, which is available at this link.
RPX Corp. (NASDAQ:RPXC) opened at 15.17 on Friday. RPX Corp. has a 1-year low of $14.55 and a 1-year high of $18.75. The stock’s 50-day moving average is $16.03 and its 200-day moving average is $16.32. The company has a market cap of $814.9 million and a P/E ratio of 24.00.
RPX Corp. (NASDAQ:RPXC) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $0.24 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.22 by $0.02. The company had revenue of $64.30 million for the quarter, compared to the consensus estimate of $63.72 million. During the same quarter last year, the company posted $0.26 earnings per share. RPX Corp.’s revenue was up 16.9% compared to the same quarter last year. Analysts expect that RPX Corp. will post $0.97 EPS for the current fiscal year.
RPXC has been the subject of a number of recent research reports. Analysts at Barclays downgraded shares of RPX Corp. from an “overweight” rating to an “equal weight” rating in a research note on Monday, August 4th. They now have a $17.00 price target on the stock, down previously from $20.00. Analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of RPX Corp. in a research note on Monday, July 21st. They now have a $19.00 price target on the stock, up previously from $18.50.
RPX Corporation (NASDAQ:RPXC) provides patent risk management solutions, offering defensive buying, acquisition syndication, patent intelligence and advisory services.
Receive News & Ratings for RPX Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RPX Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.